Reprogramming of Osimertinib-Resistant EGFR-mutant NSCLC: The Pyruvate-Acetaldehyde-Acetate Pathway As a Key Driver of ResistanceGiorgia Maroni, Elena Levantini, Beatrice Campanella et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
Deciphering the Role of Acetate in Metabolic Adaptation and Osimertinib Resistance in Non-Small Cell Lung CancerGiorgia Maroni, Emilia Bramanti, Eva Cabrera San Millán et al.|ArXiv.org|2025Cited by 0